Company profile: Sanguine Biosciences
1.1 - Company Overview
Company description
- Provider of biospecimen and biomarker services for translational biomedical research, including collection and processing of blood components, urine, stool, and skin tapes with comprehensive donor data; disease state and healthy leukopaks; human serum and plasma; lymphocyte isolation; employer onsite collection programs; and longitudinal and event-based collection.
Products and services
- Disease State & Healthy Leukopaks: Supplies enriched leukopaks with leukocytes from disease-state and healthy donors for research, enabling procurement of both disease-state and healthy leukocyte fractions
- Longitudinal Sampling & Event-Based Collection: Facilitates longitudinal biospecimen collection or event-triggered sampling within studies, aligning draws to timepoints or specified triggers to capture sequences relevant to study design
- Biospecimen and Biomarker Services: Delivers multi-matrix collection and processing of blood components, urine, stool, and skin tapes, paired with comprehensive donor data to support biomarker programs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sanguine Biosciences
Hitwise
HQ: Australia
Website
- Description: Provider of online competitive intelligence, delivering daily insights into online consumer behavior to help marketers increase campaign effectiveness. Offers data on how 25 million Internet users interact with more than 1 million websites, giving marketers a competitive advantage and helping companies grow and protect their businesses by identifying threats.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hitwise company profile →
Second Measure
HQ: United States
Website
- Description: Provider of consumer transaction data analytics using billions of anonymized purchases to answer real-time questions on company performance and consumer behavior. Offers a platform to explore transaction data; daily tracking of thousands of public and private companies; data enrichment, normalization, and visualization; and specialized analyses including subscription meals and partnership impact.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Second Measure company profile →
FlightStats
HQ: United States
Website
- Description: Provider of smart data and advanced analytics for global flight tracking and travel planning. Offers global flight status, flight monitoring and messaging, airport information, a real-time flight tracker, airport conditions, historical flight status, customizable flight alerts, on-time performance reviews, and a global aircraft emissions monitor for travelers and travel technology companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FlightStats company profile →
Healthcare Market Resources
HQ: United States
Website
- Description: Provider of in-depth local-market data and research for hospice and home healthcare marketing, supporting strategy and tactics for market share, segmentation, and business development, and benchmarking financial and operating performance against local competition.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Healthcare Market Resources company profile →
S&P Global
HQ: United States
Website
- Description: Provider of financial information and data analytics delivering market intelligence, independent credit ratings, indices and benchmarks, research, and analytics. Offers energy and commodity prices and analysis, ESG data and solutions, and automotive insights. Key offerings include S&P Global Ratings, S&P Dow Jones Indices, S&P Global Market Intelligence, S&P Global Commodity Insights, Sustainable1, and Mobility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full S&P Global company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sanguine Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sanguine Biosciences
2.2 - Growth funds investing in similar companies to Sanguine Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sanguine Biosciences
4.2 - Public trading comparable groups for Sanguine Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →